mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.3 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.3 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.3 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.3 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |